Recent Updates
Recently added Catalysts
QTI Positive Sentiment

QT Imaging to be Honored at Premier’s Annual Supplier Innovation Celebration

Tuesday, September 22, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: QT Imaging Holdings, Inc. will be honored at Premier's annual Supplier Innovation Celebration during the 2026 Breakthroughs Conference and Exhibition. The event, scheduled for October 6-8, 2026, acknowledges groundbreaking healthcare technologies. QT Imaging is recognized for its commitment to transforming breast health management with its radiation-free imaging technology.

Market Sentiment Analysis

POSITIVE FACTORS

  • QT Imaging is being recognized for its innovative technology.
  • The event highlights advancements in healthcare technology.
  • The company is dedicated to improving breast health management.

Full Press Release Details

NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced it will be honored during Premier’s annual Supplier Innovation Celebration at its 2026 Breakthroughs Conference and Exhibition, taking place October 6-8, 2026. The Innovation Celebration recognizes groundbreaking healthcare technologies launched

Frequently Asked Questions

What event will QT Imaging be honored at?

QT Imaging will be honored at Premier's annual Supplier Innovation Celebration.

When is the Supplier Innovation Celebration scheduled?

The celebration will take place from October 6-8, 2026.

What technology is QT Imaging recognized for?

QT Imaging is recognized for its innovative, radiation-free imaging technology.

What is the focus of QT Imaging's technology?

The focus is on transforming breast health management.

ShareAdd on Google
Tags: QTI Viatris Investor Conferences Healthcare QT Imaging breast health Supplier Innovation medical device healthcare technology
Last updated: Sep 22, 2026

Biotech snapshot

Cash runway
$11M liquidity · $2M/mo burn
~6 mo
High dilution risk